フロリダ州における全般性不安障害の臨床試験
フロリダ州内の拠点で、全般性不安障害に関する7件の研究が参加者を募集しています。
フロリダ州内の都市
公式研究テキスト（英語）
A Study to Asses Safety and Tolerability of ITI-1284 Given Alone or as an Additional Treatment in Participants With Generalized Anxiety Disorder (GAD)
- Sunshine Medical Research Studies Inc, Miami
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/29更新 · NCT07807865Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder
- Premier Clinical Research, Miami
- Global Medical Institutes, Miami
- Miami Dade Medical Research Institute, Miami
- 他3件
被験者募集中第2相
全年齢 · 全性別 · 2026/09/25更新 · NCT06480383Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder
- Miami Dade Medical Research Institute, Miami
- University of South Florida, Tampa
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06701903RE104 Safety and Efficacy Study in Generalized Anxiety Disorder
- Innovative Clinical Research, Inc., Lauderhill
- University of South Florida, Tampa
被験者募集中第2相
18歳〜74歳 · 全性別 · 2026/09/24更新 · NCT07489651A Trial of the Efficacy and Safety of Fixed Doses of SEP-363856 in Adults With Generalized Anxiety Disorder
- Sarkis Clinical Trials - Gainesville, Gainesville
- Clinical Neuroscience Solutions, LLC, Jacksonville
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07759128A Trial of the Efficacy and Safety of a Fixed Dose of SEP-363856 in Adults With Generalized Anxiety Disorder
- Clinical Neuroscience Solutions Inc. (CNS) - Orlando, Orlando
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/10更新 · NCT07767903Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder
- Cns Healthcare - Jacksonville /ID# 268588, Jacksonville
- Accel Research Sites Network - St. Pete /ID# 267821, Largo
- K2 Medical Research, LLC /ID# 267841, Maitland
- 他3件
被験者募集中第2相
18歳〜65歳 · 全性別 · 2026/06/17更新 · NCT06846320ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。